Word

IMPROVE YOUR PROBABILITY OF SUCCESS

Status

Dead

Status Code

710

Status Date

Friday, September 29, 2023

Serial Number

86447722

Registration Number

5161540

Registration Date

Tuesday, March 14, 2017

Mark Type

4000

Filing Date

Friday, November 7, 2014

Published for Opposition

Tuesday, October 20, 2015

Cancellation Date

Friday, September 29, 2023

Trademark Owner History

Quintiles IMS Incorporated - Original Registrant
Quintiles Transnational Corp. - Owner At Publication

Classifications

41 Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, patient management, and pharmaceutical and health products, and distributing course materials in connection therewith

35 Computerized database management and data processing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; marketing services for others, namely, creating and managing product sales and product launch programs in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business marketing consulting services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; market research and analysis services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologics; business consultation in the field of healthcare, namely, providing independent consultative review of clinical trials, peri-approval studies, post-approval studies, observational studies, post-approval surveys and clinical patient registries, post-approval marketing studies, quality improvement, and patient support programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries all excluding the provision of medical services and medical treatment services; maintaining a registry of patients; business management consultation services in the fields of healthcare organizations and electronic health records (EHR) management and optimization in the healthcare industry; business management consulting services in the healthcare, medical, health management and disease management fields; business consulting in the healthcare, medical, health management and disease management fields; providing promotional marketing services for others electronically and in person in the fields of pharmaceuticals, pharmacogenomics, biotechnical, and medical products and devices; healthcare management services, namely, providing business management services for the health care industry regarding quality improvement of patient-care programs

45 Regulatory compliance research in the development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; regulatory compliance consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory compliance audits for others to ensure the accuracy and validity of information developed in the research and testing of drugs, devices and biologics in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations; providing regulatory information, namely, providing information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory implementation services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirements

44 Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medicine and pharmaceuticals; healthcare management services, namely, developing patient-care quality improvement programs to be implemented by healthcare providers to enhance the treatment and outcomes of their patients

42 Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others; consulting services in the field of information technology related to electronic health record (EHR) data and the organizations industry; medical and scientific research in the nature of conducting peri-approval studies and post-approval studies evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies an medical services; design and development of database of patient registries; computer services, namely, providing temporary use of on-line non-downloadable computer software used for collecting, analyzing and reporting medical data relating to patient medical conditions in the area of patient registries, quality improvement programs and outcomes research; providing temporary use of non-downloadable web-based software for use in conducting patient registries, post-approval marketing studies, observational studies, electronic data capture services for post-approval marketing studies, quality improvement, and patient support and patient management programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries; providing temporary use of non-downloadable web-based clinical data management systems consisting of computer software for use in collecting, analyzing and reporting medical data relating to patient medical conditions in the area of patient registries, quality improvement programs and outcomes research and for use in conducting patient registries, post-approval marketing studies, electronic data capture services for post-approval marketing studies, quality improvement, and patient support and patient management programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries; providing an online interactive computer database in the field of scientific research used in the fields of healthcare, biopharmaceutical, and medical device and diagnostic industries; providing temporary use of web-based software application for providing access to information and data in the pharmaceutical, pharmacogenomic, biotechnical and medical products and devices, life sciences, medical, health care, health management and disease management fields and for organizing and analyzing said data and information and preparing reports therefrom; providing an internet website portal in the fields of pharmaceutical research, pharmacogenomic consultation, biotechnology consultation, investigational medical products and devices, life sciences research, and medical research; providing an online searchable database via the internet in the fields of pharmaceutical research, pharmacogenomic consultation, biotechnology consultation, investigational medical products and devices, life sciences research, and medical research

Trademark Events

Sep 29, 2023

Cancelled Sec. 8 (6-Yr)

Mar 14, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Mar 14, 2017

Registered-Principal Register

Feb 7, 2017

Notice Of Acceptance Of Statement Of Use E-Mailed

Feb 5, 2017

Allowed Principal Register - Sou Accepted

Jan 17, 2017

Statement Of Use Processing Complete

Dec 15, 2016

Use Amendment Filed

Dec 15, 2016

Teas Statement Of Use Received

Jul 23, 2016

Notice Of Approval Of Extension Request E-Mailed

Jul 22, 2016

Sou Extension 1 Granted

Jun 15, 2016

Sou Extension 1 Filed

Jul 20, 2016

Case Assigned To Intent To Use Paralegal

Jun 15, 2016

Sou Teas Extension Received

Dec 15, 2015

Noa E-Mailed - Sou Required From Applicant

Oct 20, 2015

Official Gazette Publication Confirmation E-Mailed

Oct 20, 2015

Published For Opposition

Sep 30, 2015

Notification Of Notice Of Publication E-Mailed

Sep 16, 2015

Law Office Publication Review Completed

Sep 16, 2015

Approved For Pub - Principal Register

Sep 15, 2015

Examiner's Amendment Entered

Sep 14, 2015

Assigned To Lie

Sep 14, 2015

Notification Of Examiners Amendment E-Mailed

Sep 14, 2015

Examiners Amendment E-Mailed

Sep 14, 2015

Examiners Amendment -Written

Aug 29, 2015

Teas/Email Correspondence Entered

Aug 28, 2015

Correspondence Received In Law Office

Aug 28, 2015

Teas Response To Office Action Received

May 20, 2015

Assignment Of Ownership Not Updated Automatically

Mar 1, 2015

Notification Of Non-Final Action E-Mailed

Mar 1, 2015

Non-Final Action E-Mailed

Mar 1, 2015

Non-Final Action Written

Feb 27, 2015

Assigned To Examiner

Feb 18, 2015

Assignment Of Ownership Not Updated Automatically

Nov 17, 2014

New Application Office Supplied Data Entered

Nov 11, 2014

New Application Entered